Garimorth K - Search Results

1

Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.

Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Weiss G, et al. Among authors: garimorth k. Kidney Int. 2003 Aug;64(2):572-8. doi: 10.1046/j.1523-1755.2003.00099.x. Kidney Int. 2003. PMID: 12846752 Free article. Clinical Trial.

2

The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections.

Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G. Theurl I, et al. Among authors: garimorth k. Biometals. 2005 Aug;18(4):359-67. doi: 10.1007/s10534-005-3710-1. Biometals. 2005. PMID: 16158228 Review. No abstract available.

3

Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection.

Schroecksnadel K, Zangerle R, Bellmann-Weiler R, Garimorth K, Weiss G, Fuchs D. Schroecksnadel K, et al. Among authors: garimorth k. Curr Drug Metab. 2007 Apr;8(3):225-36. doi: 10.2174/138920007780362608. Curr Drug Metab. 2007. PMID: 17430111 Review.

4

Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression.

Fritsche G, Dlaska M, Barton H, Theurl I, Garimorth K, Weiss G. Fritsche G, et al. Among authors: garimorth k. J Immunol. 2003 Aug 15;171(4):1994-8. doi: 10.4049/jimmunol.171.4.1994. J Immunol. 2003. PMID: 12902503

5

Altered immune responses during septicaemia in patients suffering from haematological malignancies.

Kurz K, Garimorth K, Joannidis M, Fuchs D, Petzer A, Weiss G. Kurz K, et al. Among authors: garimorth k. Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):147-56. doi: 10.1177/039463201202500117. Int J Immunopathol Pharmacol. 2012. PMID: 22507327 Free article.

6

Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study.

Puchner B, Sahanic S, Kirchmair R, Pizzini A, Sonnweber B, Wöll E, Mühlbacher A, Garimorth K, Dareb B, Ehling R, Wenter J, Schneider S, Brenneis C, Weiss G, Tancevski I, Sonnweber T, Löffler-Ragg J. Puchner B, et al. Among authors: garimorth k. Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198. doi: 10.23736/S1973-9087.21.06549-7. Epub 2021 Jan 15. Eur J Phys Rehabil Med. 2021. PMID: 33448756 Free article.

7

Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.

Welte T, Garimorth K, Philipp S, Doppler W. Welte T, et al. Among authors: garimorth k. Mol Endocrinol. 1994 Aug;8(8):1091-102. doi: 10.1210/mend.8.8.7527899. Mol Endocrinol. 1994. PMID: 7527899

8

Lemierre's syndrome following infectious mononucleosis.

Garimorth K, Kountchev J, Bellmann R, Semenitz B, Weiss G, Joannidis M. Garimorth K, et al. Wien Klin Wochenschr. 2008;120(5-6):181-3. doi: 10.1007/s00508-008-0937-1. Wien Klin Wochenschr. 2008. PMID: 18365159

9

Involvement of Ets-related proteins in hormone-independent mammary cell-specific gene expression.

Welte T, Garimorth K, Philipp S, Jennewein P, Huck C, Cato AC, Doppler W. Welte T, et al. Among authors: garimorth k. Eur J Biochem. 1994 Aug 1;223(3):997-1006. doi: 10.1111/j.1432-1033.1994.tb19078.x. Eur J Biochem. 1994. PMID: 8055977 Free article.

10

Generation of carboxy-terminally deleted forms of STAT5 during preparation of cell extracts.

Garimorth K, Welte T, Doppler W. Garimorth K, et al. Exp Cell Res. 1999 Jan 10;246(1):148-51. doi: 10.1006/excr.1998.4289. Exp Cell Res. 1999. PMID: 9882524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page